Low-Dose Acetylsalicylic Acid Treatment in Non-Skull-Base Meningiomas: Impact on Tumor Proliferation and Seizure Burden.
acetylsalicylic acid
aspirin
meningioma
proliferation
seizure
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
01 Sep 2022
01 Sep 2022
Historique:
received:
18
07
2022
revised:
26
08
2022
accepted:
31
08
2022
entrez:
9
9
2022
pubmed:
10
9
2022
medline:
10
9
2022
Statut:
epublish
Résumé
MIB-1 index is an important predictor of meningioma progression and was found to be correlated with COX-2 expression. However, the impact of low-dose acetylsalicylic acid (ASA) on MIB-1 index and clinical symptoms is unclear. Between 2009 and 2022, 710 patients with clinical data, tumor-imaging data, inflammatory laboratory (plasma fibrinogen, serum C-reactive protein) data, and neuropathological reports underwent surgery for primary cranial WHO grade 1 and 2 meningioma. ASA intake was found to be significantly associated with a low MIB-1 labeling index in female patients ≥ 60 years. Multivariable analysis demonstrated that female patients ≥ 60 years with a non-skull-base meningioma taking ASA had a significantly lower MIB-1 index (OR: 2.6, 95%: 1.0-6.6,
Identifiants
pubmed: 36077817
pii: cancers14174285
doi: 10.3390/cancers14174285
pmc: PMC9454729
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Neurosci Lett. 2017 Apr 3;645:106-112
pubmed: 28259657
Acta Neuropathol. 2005 Dec;110(6):537-46
pubmed: 16231158
Int J Cancer. 2019 Jul 1;145(1):267-273
pubmed: 30575949
PLoS One. 2014 Dec 31;9(12):e114633
pubmed: 25551641
J Clin Pathol. 1998 Oct;51(10):716-24
pubmed: 10023332
J Child Neurol. 2013 Feb;28(2):213-8
pubmed: 23112247
PLoS One. 2013 Oct 01;8(10):e74798
pubmed: 24098347
Br J Cancer. 2013 Mar 19;108(5):1189-94
pubmed: 23449355
Brain Tumor Pathol. 2014 Jan;31(1):23-30
pubmed: 23250387
Neuropathol Appl Neurobiol. 2009 Feb;35(1):82-8
pubmed: 19187060
Cancers (Basel). 2022 Feb 18;14(4):
pubmed: 35205781
Int J Cancer. 2017 Jan 15;140(2):346-357
pubmed: 27615282
J Neurosurg. 2021 Dec 10;:1-10
pubmed: 35099915
J Clin Oncol. 2017 Jul 20;35(21):2439-2449
pubmed: 28640707
Cureus. 2017 Nov 23;9(11):e1873
pubmed: 29383295
Acta Neurochir (Wien). 2019 Dec;161(12):2553-2561
pubmed: 31637512
Oncotarget. 2017 Oct 11;8(60):102486-102498
pubmed: 29254264
Cancer Res. 2007 Sep 15;67(18):8900-5
pubmed: 17875732
Diagnostics (Basel). 2022 Mar 30;12(4):
pubmed: 35453901
Int J Cell Biol. 2010;2010:215158
pubmed: 20339581
World Neurosurg. 2017 Jan;97:538-546
pubmed: 27777150
Neurosurg Rev. 2006 Oct;29(4):293-6; discussion 296-7
pubmed: 16953450
Biochim Biophys Acta. 2007 Nov;1773(11):1605-18
pubmed: 17945363
J Neurosurg. 2012 Jul;117(1):121-8
pubmed: 22559847
J Clin Pathol. 1988 Mar;41(3):314-9
pubmed: 3258871
Neurosurgery. 1993 Aug;33(2):204-10; discussion 211
pubmed: 8367041
J Korean Neurosurg Soc. 2011 Jan;49(1):26-30
pubmed: 21494359
Semin Cancer Biol. 2008 Oct;18(5):349-55
pubmed: 18467122
Mech Ageing Dev. 2016 Jun;156:25-33
pubmed: 27059724
Epilepsy Behav. 2013 Apr;27(1):115-7
pubmed: 23399946
J Clin Med. 2021 Apr 01;10(7):
pubmed: 33916167
Cancers (Basel). 2021 Jul 20;13(14):
pubmed: 34298854
Curr Opin Pharmacol. 2013 Aug;13(4):595-601
pubmed: 23773801
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
Oncologist. 2007 Oct;12(10):1225-36
pubmed: 17962616
Mol Pharmacol. 2008 May;73(5):1444-53
pubmed: 18094072
Prostaglandins Other Lipid Mediat. 2003 Jul;71(3-4):205-16
pubmed: 14518562
Neurosurgery. 2018 Feb 1;82(2):E52-E54
pubmed: 29309638
Medicine (Baltimore). 2020 Feb;99(9):e18644
pubmed: 32118704
APMIS. 2014 Jan;122(1):16-24
pubmed: 23756256
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6973-9
pubmed: 25400783
Prostaglandins Leukot Essent Fatty Acids. 2005 Sep-Oct;73(3-4):163-77
pubmed: 16125378
Cancer Lett. 2018 Apr 28;420:247-258
pubmed: 29408203
Acta Neuropathol. 1996;91(5):504-10
pubmed: 8740231
Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15178-83
pubmed: 15471991
BMC Cancer. 2010 Mar 25;10:112
pubmed: 20338029
Cell Rep. 2021 Aug 24;36(8):109599
pubmed: 34433020
Oncotarget. 2015 Oct 6;6(30):29637-50
pubmed: 26359357
J Neuroinflammation. 2019 Oct 30;16(1):197
pubmed: 31666079
Neuro Oncol. 2014 May;16(5):735-47
pubmed: 24536048
J Cell Physiol. 2019 May;234(5):5683-5699
pubmed: 30341914
Cancer. 2008 Dec 15;113(12):3355-63
pubmed: 18988291
J Neurosurg. 1997 Oct;87(4):610-4
pubmed: 9322850
Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):e14-7
pubmed: 16293793
Int J Cancer. 1983 Jan 15;31(1):13-20
pubmed: 6339421
J Cell Physiol. 2000 Mar;182(3):311-22
pubmed: 10653597
Cancer. 2007 Feb 1;109(3):588-97
pubmed: 17177201
Neurooncol Adv. 2019 Sep 19;1(1):vdz018
pubmed: 32642654
Front Oncol. 2020 Aug 28;10:1522
pubmed: 32983999
Neurosurg Rev. 2021 Feb;44(1):381-387
pubmed: 31834543
J Neurosurg. 2014 Nov;121(5):1189-200
pubmed: 25148008
Nat Immunol. 2010 Oct;11(10):889-96
pubmed: 20856220
J Neurosurg. 2005 Sep;103(3):508-17
pubmed: 16235684
Neuro Oncol. 2015 Oct;17 Suppl 4:iv1-iv62
pubmed: 26511214
Neurosurgery. 2011 Jul;69(1):72-8; discussion 78-9
pubmed: 21346660
Biomedicines. 2018 Aug 06;6(3):
pubmed: 30082628
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
PLoS One. 2009 Jul 29;4(7):e6412
pubmed: 19641607
Clin Neurol Neurosurg. 2010 Apr;112(3):177-82
pubmed: 20056312